Creo Medical’s device receives FDA 510(k) approval & more — 6 GI company key notes

Here are six updates on GI companies from the past week:

Advertisement

Creo Medical Group‘s Speedboat RS2 device and Croma platform received FDA 510(k) clearance.

RedHill Biopharma entered into a commercialization agreement with ParaPRO to promote RedHill’s Esomeprazole Strontium Delayed-Release capsules.

TopConsumerReviews.com awarded Bowtrol a five-star rating based on consumer feedback.

CDx Diagnostics’ Wats3D detected high-grade dysplasia and esophageal adenocarcinomas at a 400 percent higher rate when compared to the standard Seattle protocol random forceps biopsy.

Caret Pharma is acquiring Moberg Pharma AB’s Fiber Choice, a line of prebiotic fiber-based dietary supplements.

Qiagen and Clinical Genomics combined the PAXgene Blood ccfDNA Tube sample collection system into Clinical Genomics’ Colvera colorectal cancer recurrence assay.

More articles on gastroenterology:
GI center to know: Center for Colonoscopy Excellence
Metro Health adds seven gastroenterologists — 3 key notes
GI leader to know: Dr. Frank Farrell of Center for Colonoscopy Excellence

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.